Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IXJ vs DLHIX overlap: 45% of top holdings shared

Bottom line

How much do IXJ and DLHIX overlap?

45% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 41.2% of IXJ's assets and 36.7% of DLHIX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

IXJDLHIX
Weight overlap (top 25)45%
Shared holdings11
Weight in shared holdings41.2%36.7%
Total positions124108
Expense ratio0.38%0.96%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings IXJ and DLHIX have in common

Holding% of IXJ% of DLHIXOverlap
Eli Lilly And Company10.93%4.16%4.16%
Abbvie Inc.5.12%4.19%4.19%
Unitedhealth Group Incorporated4.40%3.88%3.88%
Merck & Co., Inc.4.12%3.68%3.68%
Astrazeneca Plc3.76%3.27%3.27%
Roche Holding AG3.75%3.01%3.01%
Amgen Inc.2.54%2.27%2.27%
Gilead Sciences, Inc.2.04%3.54%2.04%
Pfizer Inc.1.78%3.84%1.78%
Vertex Pharmaceuticals Incorporated1.64%1.66%1.64%
Elevance Health, Inc.1.09%3.25%1.09%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IXJ

  1. Johnson & Johnson — 7.04%
  2. Novartis AG — 3.71%
  3. Thermo Fisher Scientific Incorporated — 2.42%
  4. Abbott Laboratories — 2.05%
  5. Novo Nordisk A/s — 1.99%
  6. Intuitive Surgical, Inc. — 1.83%
  7. Cvs Health Corporation — 1.71%
  8. Danaher Corporation — 1.56%
  9. Bristol-myers Squibb Company — 1.53%
  10. Stryker Corporation — 1.41%
  11. Gsk Plc — 1.38%
  12. Medtronic Public Limited Company — 1.30%
  13. Sanofi Sa — 1.18%
  14. Mckesson Corporation — 1.18%

Only in DLHIX

  1. Ucb Sa — 5.19%
  2. Regeneron Pharmaceuticals Inc — 3.91%
  3. Chugai Pharmaceutical Co Ltd — 2.77%
  4. Viatris Inc — 2.48%
  5. Oruka Therapeutics Inc — 2.41%
  6. Halozyme Therapeutics Inc — 2.30%
  7. Illumina Inc — 2.11%
  8. Alkermes Plc — 1.82%
  9. Viking Therapeutics Inc — 1.72%
  10. Roivant Sciences Ltd — 1.60%
  11. Neurocrine Biosciences Inc — 1.57%
  12. Arcus Biosciences Inc — 1.56%
  13. Zimmer Biomet Holdings Inc — 1.42%
  14. Boston Scientific Corp — 1.42%

Asset mix

Asset typeIXJDLHIX
Stocks99.6%94.8%
Preferred stock—3.0%
Cash & short-term funds1.3%2.0%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryIXJDLHIX
US70.6%75.4%
CH10.4%3.0%
GB5.8%3.3%
BE0.5%5.2%
JP3.7%2.8%
IE1.6%3.2%
DK2.3%—
FR2.0%2.0%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do IXJ and DLHIX overlap?
About 45% by weight. 11 securities appear in both funds' top 25 holdings; they make up 41.2% of IXJ's assets and 36.7% of DLHIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do IXJ and DLHIX have in common?
The largest shared holdings are Abbvie Inc., Eli Lilly And Company, Unitedhealth Group Incorporated, Merck & Co., Inc., Astrazeneca Plc.
Should I own both IXJ and DLHIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, IXJ or DLHIX?
IXJ is broader, with 124 positions versus 108 for DLHIX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.